Investment analysts at Truist Financial assumed coverage on shares of Accenture (NYSE:ACN – Get Free Report) in a research note issued on Tuesday, Marketbeat Ratings reports. The brokerage set a “buy” rating and a $317.00 price target on the information technology services provider’s stock. Truist Financial’s price objective indicates a potential upside of 15.69% from the company’s current price.
A number of other brokerages also recently commented on ACN. The Goldman Sachs Group reissued a “buy” rating and issued a $330.00 target price on shares of Accenture in a research note on Thursday, December 18th. BMO Capital Markets reiterated a “market perform” rating and issued a $300.00 price target on shares of Accenture in a report on Thursday, December 18th. Evercore ISI restated an “outperform” rating and set a $300.00 price objective on shares of Accenture in a research note on Thursday, December 18th. Argus lowered their target price on Accenture from $370.00 to $335.00 and set a “buy” rating for the company in a research note on Monday, December 29th. Finally, Susquehanna boosted their price target on Accenture from $270.00 to $277.00 and gave the stock a “neutral” rating in a research report on Friday, December 19th. One analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating, eleven have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Accenture presently has an average rating of “Moderate Buy” and a consensus price target of $295.84.
View Our Latest Research Report on Accenture
Accenture Stock Performance
Accenture (NYSE:ACN – Get Free Report) last posted its earnings results on Thursday, December 18th. The information technology services provider reported $3.94 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.73 by $0.21. The firm had revenue of $18.74 billion during the quarter, compared to the consensus estimate of $18.51 billion. Accenture had a net margin of 10.76% and a return on equity of 26.65%. The company’s revenue was up 5.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $3.59 EPS. Accenture has set its FY 2026 guidance at 13.520-13.900 EPS. Equities analysts anticipate that Accenture will post 12.73 earnings per share for the current year.
Insider Transactions at Accenture
In related news, CEO Julie Spellman Sweet sold 5,917 shares of the company’s stock in a transaction on Wednesday, November 5th. The shares were sold at an average price of $246.62, for a total value of $1,459,250.54. Following the sale, the chief executive officer directly owned 8,599 shares of the company’s stock, valued at $2,120,685.38. This represents a 40.76% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Ryoji Sekido sold 2,500 shares of the firm’s stock in a transaction on Wednesday, October 22nd. The stock was sold at an average price of $249.47, for a total transaction of $623,675.00. Following the transaction, the chief executive officer directly owned 1,390 shares of the company’s stock, valued at approximately $346,763.30. This represents a 64.27% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 35,151 shares of company stock valued at $8,841,525 over the last ninety days. 0.02% of the stock is currently owned by corporate insiders.
Institutional Investors Weigh In On Accenture
A number of institutional investors have recently made changes to their positions in the company. Norway Savings Bank raised its holdings in Accenture by 0.9% during the second quarter. Norway Savings Bank now owns 4,123 shares of the information technology services provider’s stock worth $1,232,000 after purchasing an additional 36 shares in the last quarter. Firethorn Wealth Partners LLC increased its position in shares of Accenture by 4.4% during the 2nd quarter. Firethorn Wealth Partners LLC now owns 854 shares of the information technology services provider’s stock valued at $255,000 after purchasing an additional 36 shares during the period. Wealthcare Advisory Partners LLC raised its stake in shares of Accenture by 0.8% in the 2nd quarter. Wealthcare Advisory Partners LLC now owns 4,902 shares of the information technology services provider’s stock worth $1,465,000 after buying an additional 38 shares in the last quarter. Piscataqua Savings Bank lifted its holdings in shares of Accenture by 5.3% in the second quarter. Piscataqua Savings Bank now owns 796 shares of the information technology services provider’s stock valued at $238,000 after buying an additional 40 shares during the period. Finally, Holt Capital Advisors L.L.C. dba Holt Capital Partners L.P. grew its holdings in Accenture by 0.9% during the third quarter. Holt Capital Advisors L.L.C. dba Holt Capital Partners L.P. now owns 4,416 shares of the information technology services provider’s stock worth $1,089,000 after acquiring an additional 41 shares during the period. 75.14% of the stock is currently owned by institutional investors.
Key Accenture News
Here are the key news stories impacting Accenture this week:
- Positive Sentiment: Truist began coverage on ACN with a “buy” and $317 price target, giving the stock visible analyst backing and implying meaningful upside. Accenture (ACN) Has a New Rating from Truist Financial
- Positive Sentiment: Accenture agreed to acquire Faculty, an AI-native services/products firm — a deal that expands its GenAI capabilities and go‑to‑market for client AI transformations. This is a strategic revenue-growth catalyst. Accenture to Acquire Faculty to Scale AI Capabilities
- Positive Sentiment: Partnership with NTT DOCOMO GLOBAL to build Universal Wallet Infrastructure showcases Accenture’s positioning in large data-led, identity and digital‑trust initiatives — another strategic growth opportunity. NTT DOCOMO GLOBAL and Accenture Launch Universal Wallet Infrastructure
- Neutral Sentiment: Coverage and valuation pieces are taking stock of the AI M&A and partnerships — useful context for investors but not an immediate catalyst on their own. Assessing Accenture (ACN) Valuation After New AI Acquisition And Digital Trust Partnership
- Neutral Sentiment: Rothschild & Co Redburn adjusted its price target (low relative to the stock) and maintained neutral — a reminder that some analysts remain cautious about near‑term upside. Rothschild & Co Redburn adjusts PT
- Negative Sentiment: Coverage flagged softer public‑sector demand, which could pressure consulting revenue in the near term and weigh on sentiment for a material part of Accenture’s business. Is Softer Public-Sector Demand Undermining the Resilience of Accenture’s Consulting Engine?
- Negative Sentiment: Insider selling: CEO Mauro Macchi sold 500 shares and General Counsel Joel Unruch sold 1,332 shares in early January. Sizeable insiders remain invested, but these disclosed sales can create short‑term negative optics. SEC Filing – CEO Sale SEC Filing – GC Sale
About Accenture
Accenture is a global professional services company that provides a broad range of services and solutions in strategy, consulting, digital, technology and operations. The firm works with organizations across industries to design and implement business transformation programs, deploy and manage enterprise technology, optimize operations, and develop customer and digital experiences. Its offerings encompass management and technology consulting, systems integration, application and infrastructure services, cloud migration and managed services, as well as security and analytics capabilities.
The company delivers industry- and function-specific solutions, combining consulting expertise with proprietary tools, platforms and partnerships with major technology vendors.
See Also
- Five stocks we like better than Accenture
- You Still Think Silver’s a Joke? Watch What Happens Next.
- A U.S. “birthright” claim worth trillions – activated quietly
- A month before the crash
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- YDES Could Be 2026’s Biotech Breakthrough
Receive News & Ratings for Accenture Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accenture and related companies with MarketBeat.com's FREE daily email newsletter.
